News and Resources

News and resources

Three new Board members join IFFIm as it marks 20 years

01 Oct 2026

Philip Brown, Alex Friedman and Sungsup Ra join the IFFIm Board, bringing experience from across capital markets, investment, impact measurement and development finance as the organisation considers what its proven financing model needs for the years ahead.

Vaccine impact: rubella birth defects drop by almost 75% since 2012

30 Jul 2026

New modelling by the US CDC shows the impact that increasing access to the rubella vaccine has had on cases of congenital rubella syndrome.

Burundi bids to end its leading cancer killer, beating back misinformation

05 Jun 2026

Burundi has now integrated the HPV vaccine into its routine immunisation programme, with 84.4% of eligible girls reached in the introductory campaign.

In Nigeria, lessons from polio campaigns are helping protect children against other diseases

15 May 2026

From micro-planners to tally sheets and trackers, tools used during the years-long polio eradication efforts are boosting routine immunisation coverage.

Two years after the introduction of the malaria vaccine, Burkina Faso celebrates its impact

24 Apr 2026

Malaria cases and deaths declined significantly in 2025, according to national data.

IFFIm returns to market with US$1 billion 5-year bond to support global vaccine programs

22 Apr 2026

Funds to support Gavi immunisation programmes. This bond marks 20 years since IFFIm’s inaugural issuance.

Italy: A founding partner and longstanding leader in vaccine financing

25 Mar 2026

For nearly two decades, Italy has been a leading supporter of global immunisation through IFFIm, of which it is a founding member.